Literature DB >> 12787569

Biology of FasL.

Hae-ock Lee1, Thomas A Ferguson.   

Abstract

FasL (CD95L) is a well-known and well-characterized death-inducing ligand. Spontaneous mutations in FasL and its cognate receptor Fas (CD95) have helped understand the role of these molecules in the disease. Once thought to be mainly involved in the homeostasis of immune system, the territory of FasL regulation has been expanded to angiogenesis and tumor progression. Here, we review what is currently known about the role of FasL in many areas of biology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787569     DOI: 10.1016/s1359-6101(03)00028-5

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  14 in total

1.  Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes.

Authors:  G Jaita; M Candolfi; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2005-08-11       Impact factor: 4.736

2.  Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.

Authors:  J-Y Chen; C-M Wang; S-C Lu; Y-H Chou; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Genetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.

Authors:  Ping Liu; Zibai Wei; Xiaofeng He; Junyan Yu; Xiangyang Tian; Jianlan Chang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines.

Authors:  Katherine S Koch; Kyung-Hwa Son; Rene Maehr; Illenia Pellicciotta; Hidde L Ploegh; Maurizio Zanetti; Stewart Sell; Hyam L Leffert
Journal:  Immunology       Date:  2006-07-10       Impact factor: 7.397

5.  Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.

Authors:  Seyfi Yıldır; Melek Sezgin; Ibrahim Ömer Barlas; Gözde Türköz; Handan Çamdeviren Ankaralı; Günşah Şahin; Mehmet Emin Erdal
Journal:  Rheumatol Int       Date:  2013-06-09       Impact factor: 2.631

Review 6.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

7.  Fas/Fas ligand-mediated apoptosis in different cell lineages and functional compartments of human lymph nodes.

Authors:  Tuomo S Kokkonen; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2010-02       Impact factor: 2.479

8.  Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.

Authors:  Norito Sugi; Emily A Whiston; Bruce R Ksander; Meredith S Gregory
Journal:  Infect Immun       Date:  2013-04-08       Impact factor: 3.441

9.  Ocular Inflammatory Disorders in Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Didar Ucar; Jane S Kim; Rachel J Bishop; Robert B Nussenblatt; V Koneti Rao; H Nida Sen
Journal:  Ocul Immunol Inflamm       Date:  2016-05-26       Impact factor: 3.070

10.  FasL expression on human nucleus pulposus cells contributes to the immune privilege of intervertebral disc by interacting with immunocytes.

Authors:  Zhi-Heng Liu; Zhen Sun; Hai-Qiang Wang; Jun Ge; Ting-Shuai Jiang; Yu-Fei Chen; Ying Ma; Chen Wang; Sheng Hu; Dino Samartzis; Zhuo-Jing Luo
Journal:  Int J Med Sci       Date:  2013-06-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.